NIH clinical trial of investigational vaccine for COVID-19 began in Seattle
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
-
-
Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Vaccine
Hologic’s molecular test for the novel Coronavirus, SARS-CoV-2, receives FDA Emergency Use Authorization
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
-
BD, BioGX announced FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
-
Sanofi and Regeneron began global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19
On Mar. 16, 2020, Sanofi and Regeneron Pharma announced they have started a clinical program evaluating Kevzara (sarilumab)…
-
Meridian Bioscience supports companies in fighting Coronavirus withg zero cost proprietary technology for evaluation
On Mar. 16, 2020, Meridian Bioscience announced its increased commitment to the global fight against COVID-19 by making…
-
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
-
Large scale COVID-19 testing of general population begun in Iceland
On Mar. 15, 2020, Iceland health authorities and deCode Genetics announced they began comprehensive screening for the virus…
-
Johnson & Johnson collaborated with Beth Israel Deaconess Medical Center to accelerate COVID-19 vaccine development
On Mar. 13, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical Companies have entered a collaboration with…
-
BioReference Laboratories offers testing for Coronavirus disease 2019 (COVID-19)
On Mar. 13, 2020, BioReference Laboratories, an OPKO company, announced it had begun accepting specimens for testing of…
-
Luminex provided update on SARS-CoV-2 validation testing efforts
On Mar. 13, 2020, Luminex announced that four independent clinical laboratories had validated laboratory developed tests (LDTs) for…
-
Roche announced FDA Emergency Use Authorization and availablabilityof cobas SARS-CoV-2 detection test
On Mar. 13, 2020, Roche announced the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization…
-
Biotechnology | COVID-19 | Diagnostics | FDA
FDA issued Emergency Use Authorization to Thermo Fisher Scientific for diagnostic test for COVID-19
On Mar. 13, 2020, Thermo Fisher Scientific announced the U.S. Food and Drug Administration (FDA) has issued an emergency…
-
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine | WHO
National Emergency declared in U.S. for novel Coronavirus disease outbreak
On Mar. 13, 2020, declared a COVID-related emergency under Section 501(b) of the Stafford Act [18]. Under the…
-
Enanta Pharmaceuticals announced efforts to discover treatment for novel Coronavirus disease
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
-
Leading veterinary diagnostic company saw no COVID-19 cases in pets early in Pandemic
On Mar. 13, 2020, IDEXX Laboratories announced the company had seen no positive results in pets to date…
-
Qatar reported one confirmed case of Middle East Respiratory Syndrome Coronavirus infection
On May 12, 2022, the National IHR Focal Point for Qatar reported two laboratory-confirmed cases of Middle East…
-
Pluristem and Charit’ University of Medicine Berlin joinly target potential treatment for respiratory and inflammatory Intratissue complications caused by COVID-19
On Mar. 12, 2020, Pluristem Therapeutics announced it a collaborative agreement with the BIH Center for Regenerative Therapy…
-
Vir Biotec announced intent to collaborate with Biogen on manufacturing of antibodies to potentially treat COVID-19
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
-
Innovation Pharma announced testing procedures of Brilacidin against Coronavirus
On Mar. 12, 2020, Innovation Pharma announced research procedures that one of the 12 Regional Biocontainment Labs (RBLs)…
-
Predictive Oncology launched new AI platform for vaccine and drug development targeting coronaviruses and Acute Respiratory Syndromes
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
-
Mayo Clinic developed test to detect COVID-19 infection
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
-
Emergent BioSolutions initiated development of product candidates for treatment of Coronavirus
On Mar. 11, 2020, Emergent BioSolutions announced it has initiated development of two product candidates for treatment and…
-
La Jolla Institute for Immunology identified potential targets for immune responses to novel coronavirus
On Mar. 11, 2020, the La Jolla Institute for Immunology (LJI) and the J. Craig Venter Institute announced…
-
CaroGen and Yale scientists joined to develop a COVID-19 vaccine
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
-
U.S. Regional Biocontainment Lab to begin testing of Brilacidin against Coronavirus (COVID-19)
On Mar. 10, 2020, Innovation Pharma announced that management was advised that testing of Brilacidin, the Company’s flagship…
-
CerTest Biotec and BD announced COVID-19 diagnostic test
On Mar. 10, 2020, BCerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress
Innovation Pharma Brilacidin received by US Regional Biocontainment Lab for testing against COVID-19
On Mar. 9, 2020, Innovation Pharmaceuticals announced it was notified by one of the 12 Regional Biocontainment Labs…
-
Ampligen to be tested by Japan’s National Institute of Infectious Diseases as potential treatment for SARS-CoV-2
On Mar. 9, 2020, AIM ImmunoTech announced that the National Institute of Infectious Diseases (NIID) in Japan will…
-
UTSW researchers and international collaborators found human protein that potently inhibits coronavirus
On Mar. 8, 2020, an international team of investigators reported finding a protein produced by the human immune…
